Deutsche Bank
MRNS

Deutsche Bank’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Deutsche Bank’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,898
Closed -$234K – 3753
2024
Q1 		$234K Buy
25,898
+685
+3% +$6.66K ﹤0.01% 2750
2023
Q4 		$274K Sell
25,213
-748
-3% -$5.61K ﹤0.01% 2698
2023
Q3 		$209K Buy
25,961
+3,321
+15% +$27.6K ﹤0.01% 2748
2023
Q2 		$246K Buy
+22,640
New +$194K ﹤0.01% 2770
2022
Q2 		– Sell
-20,984
Closed -$196K – 4378
2022
Q1 		$196K Sell
20,984
-2,378
-10% -$23.6K ﹤0.01% 3281
2021
Q4 		$277K Buy
23,362
+1,182
+5% +$13.7K ﹤0.01% 3205
2021
Q3 		$253K Sell
22,180
-684
-3% -$9.41K ﹤0.01% 3449
2021
Q2 		$410K Buy
22,864
+3,603
+19% +$58K ﹤0.01% 3349
2021
Q1 		$298K Buy
19,261
+804
+4% +$11.6K ﹤0.01% 3418
2020
Q4 		$225K Buy
18,457
+4,409
+31% +$61.5K ﹤0.01% 3405
2020
Q3 		$181K Buy
14,048
+3,388
+32% +$29.2K ﹤0.01% 3270
2020
Q2 		$108K Buy
10,660
+3,242
+44% +$29.8K ﹤0.01% 3399
2020
Q1 		$60K Sell
7,418
-2,509
-25% -$21.7K ﹤0.01% 3463
2019
Q4 		$84K Buy
9,927
+6,342
+177% +$35.6K ﹤0.01% 3669
2019
Q3 		$20K Sell
3,585
-6,421
-64% -$51.9K ﹤0.01% 4327
2019
Q2 		$165K Sell
10,006
-10,144
-50% -$176K ﹤0.01% 3937
2019
Q1 		$335K Buy
20,150
+8,218
+69% +$118K ﹤0.01% 3692
2018
Q4 		$135K Sell
11,932
-10,135
-46% -$205K ﹤0.01% 4079
2018
Q3 		$883K Buy
22,067
+1,812
+9% +$51.6K ﹤0.01% 3420
2018
Q2 		$572K Sell
20,255
-66,066
-77% -$1.46M ﹤0.01% 3780
2018
Q1 		$1.32M Sell
86,321
-17,733
-17% -$422K ﹤0.01% 3145
2017
Q4 		$3.4M Buy
104,054
+104,004
+208,008% +$2.8M ﹤0.01% 2354
2017
Q3 		$1K Buy
50
+10
+25% +$112 ﹤0.01% 4836
2017
Q2 		$0 Sell
40
-85
-68% -$459 ﹤0.01% 5167
2017
Q1 		$0 Buy
+125
New +$672 ﹤0.01% 5146
2016
Q1 		– Sell
-254
Closed -$7K – 5381
2015
Q4 		$7K Buy
+254
New +$7.45K ﹤0.01% 5010
2015
Q3 		– Sell
-75
Closed -$3K – 5379
2015
Q2 		$3K Buy
+75
New +$2.8K ﹤0.01% 5201
2015
Q1 		– Sell
-64
Closed -$2K – 6104
2014
Q4 		$2K Sell
64
-36
-36% -$1.04K ﹤0.01% 6022
2014
Q3 		$2K Buy
+100
New +$3.09K ﹤0.01% 5685

Other funds holding MRNS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank's MRNS Position: Q2 2024 in Review

Deutsche Bank sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 25,898 shares — an estimated $234K sold.

Deutsche Bank first reported a position in MRNS in Q3 2014 and held it in 29 quarters. The position peaked at $3.4M in Q4 2017. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • Deutsche Bank reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • Deutsche Bank sold 25,898 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $234K.
  • Deutsche Bank first reported a position in Marinus Pharmaceuticals, Inc in Q3 2014 and held it in 29 quarters.
  • Deutsche Bank's Marinus Pharmaceuticals, Inc position peaked at $3.4M in Q4 2017.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.